I don't think that there's enough research out there to say, oh, this is a safe thing for you to take
are offering full unlimited access to GLP-1s for weight loss for their populations due to the high cost
Here are 8 potential reasons why not to prescribe Lixisenatide: 1- this is only one small study and only one dose was tested, 2- Lixisenatide is not currently available at pharmacies, 3- the weight loss associated with this GLP-1 is not desirable in many cases of Parkinsons disease where weight loss is an issue, 4- non-motor outcomes did not change as in other trials, and this will need to be better explained
GLP-1 Analogues vs Traditional Antidiabetic Drugs Source: Polaris Market Research Analysis GLP-1 Analogues Market Trends Rising Geriatric Population Older individuals, due to age-related factors, are at a higher risk of developing type 2 diabetes and related health conditions, resulting in a greater need for GLP-1 analogues inhibitors
Judge Marston oversees the MDL in the Eastern District of Pennsylvania
Supports Whole-Body Renewal Supports broader cellular processes associated with repair and renewal as part of a consistent wellness routine
